Perry Watts
- Oncology top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Immunology
- Co-authors
- Eric A. RossSamuel LitwinAndres J. Klein–SzantoJonathan D. ChengLeonard R. HenryWen‐Tien ChenJohn S. LeeHyung‐Ok Lee
- Topics
- Monoclonal and Polyclonal Antibodies Research (3 papers)Cancer Treatment and Pharmacology (2 papers)vaccines and immunoinformatics approaches (2 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United States
In The Last Decade
Perry Watts
18 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 109
- Oncology 489
- Molecular Biology 306
- Pulmonary and Respiratory Medicine 241
- Cancer Research 211
- Immunology 199
Countries citing papers authored by Perry Watts
This map shows the geographic impact of Perry Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Watts more than expected).
Fields of papers citing papers by Perry Watts
This network shows the impact of papers produced by Perry Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Watts. The network helps show where Perry Watts may publish in the future.
Co-authorship network of co-authors of Perry Watts
This figure shows the co-authorship network connecting the top 25 collaborators of Perry Watts. A scholar is included among the top collaborators of Perry Watts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perry Watts. Perry Watts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 109 | |
| 2 | 299 | |
| 3 | 29 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 34 | |
| 7 | 44 | |
| 8 | 143 | |
| 9 | 13 | |
| 10 | Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma. | 6 |
| 11 | Women's responses to the mammography experience. | 31 |
| 12 | 5 | |
| 13 | A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16. | 59 |
| 14 | 25 | |
| 15 | 206 | |
| 16 | 10 | |
| 17 | Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon. | 19 |
| 18 | Effects of formaldehyde on normal xenotransplanted human tracheobronchial epithelium. | 9 |
About Perry Watts
Perry Watts is a scholar working on Radiology, Nuclear Medicine and Imaging, Virology and Cancer Research, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers) and vaccines and immunoinformatics approaches (2 papers). The work is most often cited by research in Oncology (489 citations), Cancer Research (211 citations) and Immunology (199 citations). Perry Watts has collaborated with scholars based in United States. Frequent co-authors include Eric A. Ross, Samuel Litwin, Andres J. Klein–Szanto, Jonathan D. Cheng, Leonard R. Henry, Wen‐Tien Chen, John S. Lee, Hyung‐Ok Lee, Jeffrey J Stewart and Mark J. Shlomchik. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and BMC Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.